MoneyWorks4Me

Adar Poonawalla offloads entire stake in Panacea Biotec

18 May 2021 Evaluate

Serum Institute of India CEO Adar Poonawalla has offloaded his entire stake in Panacea Biotec amounting to 5.15 per cent shareholding of the firm for Rs 118 crore, through an open market transaction. The shares were picked by Serum Institute of India (SII).

Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..